Splenomegaly in oxaliplatin-naive patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy in stage IV or recurrent colorectal cancer
Splenomegaly in oxaliplatin-naive patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy in stage IV or recurrent colorectal cancer
复制标题
IV 期或复发性结直肠癌化疗前天冬氨酸转氨酶与血小板的比率可以预测未接受奥沙利铂治疗的患者因化疗相关肝毒性而出现的脾肿大
DOI：
--
复制
发表时间：
2012
期刊：
影响因子：
--
通讯作者：
Nakano H
中科院分区：
文献类型：
--
作者：
中野浩;他;中野浩;Iimuro Y;Nakano H
